Molecular 'eat' signals slow tumors and extend survival in animal models

Researchers from Cambridge and Basel have developed small molecules that could make cancer immunotherapies more effective. They work in two ways: they prompt macrophages to engulf cancer cells and alter the surrounding tissue, reducing its ability to suppress immune attacks on the tumor.

≈